Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Rocaglamide Selectively Eradicates Human Leukemia Stem Cells and Synergizes with Multiple Agents to Target AML Cells

Kevin P Callahan, PhD, Cheryl Corbett, Steven Jacob, Mohammad Minhajuddin, PhD, Eleni D Lagadinou, MD/PhD, Randall M Rossi, MS, Valerie Gross, Marlene Balys, Fred Hagen, PhD, Alison J Frontier, PhD, Craig T. Jordan, PhD

Blood (2012) 120 (21): 1338.

https://doi.org/10.1182/blood.V120.21.1338.1338

Published: 2012

Journal Articles

Reactive Oxygen Species (ROS) Levels Define Functional Heterogeneity in Human Leukemia Stem Cells and Represent a Critical Parameter for Therapeutic Targeting

Eleni Lagadinou, MD/PhD, Kevin Callahan, PhD, Sarah J Neering, BS, ShanShan Pei, BS, Mohammad Minhajuddin, PhD, Randall M Rossi, MS, Valerie Grose, BS, Cheryl Corbett, Marlene Balys, BS, Paul Brookes, PhD, Craig T. Jordan, PhD

Blood (2011) 118 (21): 639.

https://doi.org/10.1182/blood.V118.21.639.639

Published: 2011

Journal Articles

Molecular Mechanisms of Parthenolide-Mediated Pro-Apoptotic Activity in Acute Myeloid Leukemia Cells

Mohammad Minhajuddin, PhD, Shanshan Pei, John M Ashton, Kevin Callahan, PhD, Eleni Lagadinou, MD/PhD, Marlene Balys, Cheryl Corbett, Sarah Neering, Randall M Rossi, MS, Craig T. Jordan, PhD

Blood (2011) 118 (21): 2463.

https://doi.org/10.1182/blood.V118.21.2463.2463

Published: 2011

Journal Articles

Targeting Redox Homeostasis As a Means to Selectively Eradicate Primary Human Leukemia Cells,

Shanshan Pei, Kevin Callahan, PhD, Mohammad Minhajuddin, PhD, Marlene Balys, Sarah Neering, Cheryl Corbett, Michael W. Becker, MD, Jane L. Liesveld, MD, Fred Hagen, PhD, Alan E Friedman, PhD, Peter Crooks, PhD, Craig T. Jordan, PhD

Blood (2011) 118 (21): 3506.

https://doi.org/10.1182/blood.V118.21.3506.3506

Published: 2011

Journal Articles

Troglitazone and Prochloroperazine Repositioned As An Anti-Leukemia Stem Cell Drug Combination Using Chemical Genomics-Based Prediction

Duane C Hassane, PhD, Jeanne P. De Leon, Cheryl Corbett, Randall M Rossi, MS, Wen Xie, MS, Craig T. Jordan, PhD, Monica L. Guzman, PhD

Blood (2011) 118 (21): 1885.

https://doi.org/10.1182/blood.V118.21.1885.1885

Published: 2011

Journal Articles

Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data

Duane C. Hassane, Monica L. Guzman, Cheryl Corbett, Xiaojie Li, Ramzi Abboud, Fay Young, Jane L. Liesveld, Martin Carroll, Craig T. Jordan

Blood (2008) 111 (12): 5654–5662.

https://doi.org/10.1182/blood-2007-11-126003

Published: 2008

Includes: Supplemental data

Journal Articles

A Search of Public Gene Expression Microarray Data Identifies Novel Agents That Selectively Eradicate AML Stem Cells.

Duane C. Hassane, PhD, Monica L. Guzman, PhD, Cheryl Corbett, Xiaojie Li, MD, Jane L. Liesveld, MD, Fay Young, MD, Martin Carroll, MD, Craig T. Jordan, PhD

Blood (2007) 110 (11): 776.

https://doi.org/10.1182/blood.V110.11.776.776

Published: 2007

Journal Articles

Rapid Loss of Membrane Integrity and Irreversible Commitment to Cell Death of Primary AML Stem Cells: A Novel Activity for 4-benzyl, 2-methyl,1,2,4-Thiadiazolidine,3,5 Dione (TDZD-8).

Monica L. Guzman, PhD, Xiaojie Li, BS, Cheryl Corbett, BS, Randall M. Rossi, MS, Timothy Bushnell, PhD, Craig T. Jordan, PhD

Blood (2006) 108 (11): 2535.

https://doi.org/10.1182/blood.V108.11.2535.2535

Published: 2006

Journal Articles

A Novel Orally Available Parthenolide Analog Selectively Eradicates AML Stem and Progenitor Cells.

Monica L. Guzman, PhD, Randall M. Rossi, MS, Xiaojie Li, BS, Cheryl Corbett, BS, Duane C. Hassane, PhD, Timothy Bushnell, PhD, Martin Carroll, MD, Edmund Sullivan, DVM, Sundar Neelakantan, PhD, Peter A. Crooks, PhD, Craig T. Jordan, PhD

Blood (2006) 108 (11): 237.

https://doi.org/10.1182/blood.V108.11.237.237

Published: 2006

Journal Articles

Molecular Signature for Parthenolide-Induced Apoptosis in AML CD34+ Cells Reveals Targets for Improving Induction of Leukemia-Specific Cell Death.

Duane C. Hassane, PhD, Monica L. Guzman, PhD, Xiaojie Li, MS, Cheryl Corbett, BS, Craig T. Jordan, PhD

Blood (2006) 108 (11): 2592.

https://doi.org/10.1182/blood.V108.11.2592.2592

Published: 2006

Journal Articles

Mechanisms Controlling Selective Death of Leukemia Stem Cells in Response to Parthenolide.

Monica L. Guzman, PhD, Xiaojie Li, Cheryl Corbett, Duane C. Hassane, PhD, Craig T. Jordan, PhD

Blood (2005) 106 (11): 467.

https://doi.org/10.1182/blood.V106.11.467.467

Published: 2005

NARROW

Rocaglamide Selectively Eradicates Human Leukemia Stem Cells and Synergizes with Multiple Agents to Target AML Cells

Reactive Oxygen Species (ROS) Levels Define Functional Heterogeneity in Human Leukemia Stem Cells and Represent a Critical Parameter for Therapeutic Targeting

Molecular Mechanisms of Parthenolide-Mediated Pro-Apoptotic Activity in Acute Myeloid Leukemia Cells

Targeting Redox Homeostasis As a Means to Selectively Eradicate Primary Human Leukemia Cells,

Troglitazone and Prochloroperazine Repositioned As An Anti-Leukemia Stem Cell Drug Combination Using Chemical Genomics-Based Prediction

Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data

A Search of Public Gene Expression Microarray Data Identifies Novel Agents That Selectively Eradicate AML Stem Cells.

Rapid Loss of Membrane Integrity and Irreversible Commitment to Cell Death of Primary AML Stem Cells: A Novel Activity for 4-benzyl, 2-methyl,1,2,4-Thiadiazolidine,3,5 Dione (TDZD-8).

A Novel Orally Available Parthenolide Analog Selectively Eradicates AML Stem and Progenitor Cells.

Molecular Signature for Parthenolide-Induced Apoptosis in AML CD34+ Cells Reveals Targets for Improving Induction of Leukemia-Specific Cell Death.

Mechanisms Controlling Selective Death of Leukemia Stem Cells in Response to Parthenolide.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only